The Multiple Sclerosis Severity Score: fluctuations and prognostic ability in a longitudinal cohort of patients with MS
Authors:
Open Access
- 1 January 2019
- journal article
- research article
- Published by SAGE Publications in Multiple Sclerosis Journal – Experimental, Translational and Clinical
- Vol. 5 (1)
Abstract
Background: The Multiple Sclerosis Severity Score (MSSS), combining the Expanded Disability Status Scale (EDSS) and disease duration, attempts to stratify multiple sclerosis (MS) patients based on their rate of progression. Its prognostic ability in the individual patient remains unproven. Objectives: To assess the stability of MSSS within individual persons with MS in a longitudinal cohort, to evaluate whether certain factors influence MSSS variability, and to explore the ability of MSSS to predict future ambulatory function. Methods: A single-center retrospective review was performed of patients following a single provider for at least 8 years. Mixed model regression modeled MSSS over time. A Kaplan–Meier survival plot was fitted, using change of baseline MSSS by at least one decile as the event. Cox modeling assessed the influence of baseline clinical and demographic factors on the hazard of changing MSSS by at least one decile. Linear models evaluated the impact of baseline EDSS, baseline MSSS, and other factors on the Timed 25-Foot Walk (T25FW). Results: Out of 122 patients, 68 (55.7%) deviated from baseline MSSS by at least one decile. Final T25FW had slightly weaker correlation to baseline MSSS than to baseline EDSS, which was moderately strongly correlated with future log T25FW. Conclusion: Individual MSSS scores often vary over time. Clinicians should exercise caution when using MSSS to prognosticate.Keywords
This publication has 19 references indexed in Scilit:
- Multiple Sclerosis Susceptibility Genes: Associations with Relapse Severity and RecoveryPLOS ONE, 2013
- Brain atrophy and lesion load predict long term disability in multiple sclerosisJournal of Neurology, Neurosurgery & Psychiatry, 2013
- Microcystic macular oedema in multiple sclerosis is associated with disease severityBrain, 2012
- Demyelination versus remyelination in progressive multiple sclerosisBrain, 2010
- Smoking and Disease Progression in Multiple SclerosisArchives of Neurology, 2009
- The multiple sclerosis severity score (MSSS) predicts disease severity over timeJournal of the Neurological Sciences, 2009
- Genome-wide association analysis of susceptibility and clinical phenotype in multiple sclerosisHuman Molecular Genetics, 2008
- Genome-Wide Pharmacogenomic Analysis of the Response to Interferon Beta Therapy in Multiple SclerosisArchives of Neurology, 2008
- Multiple Sclerosis Severity ScoreNeurology, 2005
- Predicting the Outcome of Optic NeuritisJournal of Neurology, 2005